Industry Research Reports
Global Octreotide Market Research Report 2025
Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 78 Pages
Report ld: 3466056
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Octreotide Market Size(US$)
CAGR 2025-2031
-2.8%
Market Size,2031
USD 2.3
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2.8 million
Market Forecast in 2031(Value)
US$ 2.3 million
CAGR
-2.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Octreotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Octreotide.
The Octreotide market size, estimations, and forecasts are provided in terms of sales volume (Gram) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Octreotide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Octreotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Segment by Type
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Segment by Application
Treating Severe Diarrhea
Treating Acromegaly
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Octreotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Octreotide Market Overview
1.1 Product Definition
1.2 Octreotide by Type
1.2.1 Global Octreotide Market Value Comparison by Type (2024 VS 2031)
1.2.2 Octreotide Injection
1.2.3 Octreotide Powder
1.2.4 Octreotide Microspheres
1.3 Octreotide by Application
1.3.1 Global Octreotide Market Value by Application (2024 VS 2031)
1.3.2 Treating Severe Diarrhea
1.3.3 Treating Acromegaly
1.3.4 Others
1.4 Global Octreotide Market Size Estimates and Forecasts
1.4.1 Global Octreotide Revenue 2020-2031
1.4.2 Global Octreotide Sales 2020-2031
1.4.3 Global Octreotide Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Octreotide Market Competition by Manufacturers
2.1 Global Octreotide Sales Market Share by Manufacturers (2020-2025)
2.2 Global Octreotide Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Octreotide Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Octreotide, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Octreotide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Octreotide, Product Type & Application
2.7 Global Key Manufacturers of Octreotide, Date of Enter into This Industry
2.8 Global Octreotide Market Competitive Situation and Trends
2.8.1 Global Octreotide Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Octreotide Players Market Share by Revenue
2.8.3 Global Octreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Octreotide Market Scenario by Region
3.1 Global Octreotide Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Octreotide Sales by Region: 2020-2031
3.2.1 Global Octreotide Sales by Region: 2020-2025
3.2.2 Global Octreotide Sales by Region: 2026-2031
3.3 Global Octreotide Revenue by Region: 2020-2031
3.3.1 Global Octreotide Revenue by Region: 2020-2025
3.3.2 Global Octreotide Revenue by Region: 2026-2031
3.4 North America Octreotide Market Facts & Figures by Country
3.4.1 North America Octreotide Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Octreotide Sales by Country (2020-2031)
3.4.3 North America Octreotide Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Octreotide Market Facts & Figures by Country
3.5.1 Europe Octreotide Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Octreotide Sales by Country (2020-2031)
3.5.3 Europe Octreotide Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Octreotide Market Facts & Figures by Region
3.6.1 Asia Pacific Octreotide Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Octreotide Sales by Region (2020-2031)
3.6.3 Asia Pacific Octreotide Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Octreotide Market Facts & Figures by Country
3.7.1 Latin America Octreotide Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Octreotide Sales by Country (2020-2031)
3.7.3 Latin America Octreotide Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Octreotide Market Facts & Figures by Country
3.8.1 Middle East and Africa Octreotide Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Octreotide Sales by Country (2020-2031)
3.8.3 Middle East and Africa Octreotide Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Octreotide Sales by Type (2020-2031)
4.1.1 Global Octreotide Sales by Type (2020-2025)
4.1.2 Global Octreotide Sales by Type (2026-2031)
4.1.3 Global Octreotide Sales Market Share by Type (2020-2031)
4.2 Global Octreotide Revenue by Type (2020-2031)
4.2.1 Global Octreotide Revenue by Type (2020-2025)
4.2.2 Global Octreotide Revenue by Type (2026-2031)
4.2.3 Global Octreotide Revenue Market Share by Type (2020-2031)
4.3 Global Octreotide Price by Type (2020-2031)
5 Segment by Application
5.1 Global Octreotide Sales by Application (2020-2031)
5.1.1 Global Octreotide Sales by Application (2020-2025)
5.1.2 Global Octreotide Sales by Application (2026-2031)
5.1.3 Global Octreotide Sales Market Share by Application (2020-2031)
5.2 Global Octreotide Revenue by Application (2020-2031)
5.2.1 Global Octreotide Revenue by Application (2020-2025)
5.2.2 Global Octreotide Revenue by Application (2026-2031)
5.2.3 Global Octreotide Revenue Market Share by Application (2020-2031)
5.3 Global Octreotide Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Octreotide Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Octreotide Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Sun Pharmaceutical
6.2.1 Sun Pharmaceutical Company Information
6.2.2 Sun Pharmaceutical Description and Business Overview
6.2.3 Sun Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sun Pharmaceutical Octreotide Product Portfolio
6.2.5 Sun Pharmaceutical Recent Developments/Updates
6.3 Chengdu Tiantaishan pharmaceutical
6.3.1 Chengdu Tiantaishan pharmaceutical Company Information
6.3.2 Chengdu Tiantaishan pharmaceutical Description and Business Overview
6.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolio
6.3.5 Chengdu Tiantaishan pharmaceutical Recent Developments/Updates
6.4 Sinopharm A-Think Pharmaceuticals
6.4.1 Sinopharm A-Think Pharmaceuticals Company Information
6.4.2 Sinopharm A-Think Pharmaceuticals Description and Business Overview
6.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolio
6.4.5 Sinopharm A-Think Pharmaceuticals Recent Developments/Updates
6.5 Sihuan Pharmaceutical Holdings Group
6.5.1 Sihuan Pharmaceutical Holdings Group Company Information
6.5.2 Sihuan Pharmaceutical Holdings Group Description and Business Overview
6.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolio
6.5.5 Sihuan Pharmaceutical Holdings Group Recent Developments/Updates
6.6 Shanghai Soho-Yiming Pharmaceuticals
6.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
6.6.2 Shanghai Soho-Yiming Pharmaceuticals Description and Business Overview
6.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolio
6.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments/Updates
6.7 Yibin Pharmaceutical
6.7.1 Yibin Pharmaceutical Company Information
6.7.2 Yibin Pharmaceutical Description and Business Overview
6.7.3 Yibin Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Yibin Pharmaceutical Octreotide Product Portfolio
6.7.5 Yibin Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Octreotide Industry Chain Analysis
7.2 Octreotide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Octreotide Production Mode & Process Analysis
7.4 Octreotide Sales and Marketing
7.4.1 Octreotide Sales Channels
7.4.2 Octreotide Distributors
7.5 Octreotide Customer Analysis
8 Octreotide Market Dynamics
8.1 Octreotide Industry Trends
8.2 Octreotide Market Drivers
8.3 Octreotide Market Challenges
8.4 Octreotide Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Octreotide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Octreotide Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Octreotide Market Competitive Situation by Manufacturers in 2024
Table 4. Global Octreotide Sales (Gram) of Key Manufacturers (2020-2025)
Table 5. Global Octreotide Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Octreotide Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Octreotide Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Octreotide Average Price (USD/Gram) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Octreotide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Octreotide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Octreotide, Product Type & Application
Table 12. Global Key Manufacturers of Octreotide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Octreotide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Octreotide as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Octreotide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Octreotide Sales by Region (2020-2025) & (Gram)
Table 18. Global Octreotide Sales Market Share by Region (2020-2025)
Table 19. Global Octreotide Sales by Region (2026-2031) & (Gram)
Table 20. Global Octreotide Sales Market Share by Region (2026-2031)
Table 21. Global Octreotide Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Octreotide Revenue Market Share by Region (2020-2025)
Table 23. Global Octreotide Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Octreotide Revenue Market Share by Region (2026-2031)
Table 25. North America Octreotide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Octreotide Sales by Country (2020-2025) & (Gram)
Table 27. North America Octreotide Sales by Country (2026-2031) & (Gram)
Table 28. North America Octreotide Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Octreotide Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Octreotide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Octreotide Sales by Country (2020-2025) & (Gram)
Table 32. Europe Octreotide Sales by Country (2026-2031) & (Gram)
Table 33. Europe Octreotide Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Octreotide Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Octreotide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Octreotide Sales by Region (2020-2025) & (Gram)
Table 37. Asia Pacific Octreotide Sales by Region (2026-2031) & (Gram)
Table 38. Asia Pacific Octreotide Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Octreotide Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Octreotide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Octreotide Sales by Country (2020-2025) & (Gram)
Table 42. Latin America Octreotide Sales by Country (2026-2031) & (Gram)
Table 43. Latin America Octreotide Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Octreotide Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Octreotide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Octreotide Sales by Country (2020-2025) & (Gram)
Table 47. Middle East and Africa Octreotide Sales by Country (2026-2031) & (Gram)
Table 48. Middle East and Africa Octreotide Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Octreotide Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Octreotide Sales (Gram) by Type (2020-2025)
Table 51. Global Octreotide Sales (Gram) by Type (2026-2031)
Table 52. Global Octreotide Sales Market Share by Type (2020-2025)
Table 53. Global Octreotide Sales Market Share by Type (2026-2031)
Table 54. Global Octreotide Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Octreotide Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Octreotide Revenue Market Share by Type (2020-2025)
Table 57. Global Octreotide Revenue Market Share by Type (2026-2031)
Table 58. Global Octreotide Price (USD/Gram) by Type (2020-2025)
Table 59. Global Octreotide Price (USD/Gram) by Type (2026-2031)
Table 60. Global Octreotide Sales (Gram) by Application (2020-2025)
Table 61. Global Octreotide Sales (Gram) by Application (2026-2031)
Table 62. Global Octreotide Sales Market Share by Application (2020-2025)
Table 63. Global Octreotide Sales Market Share by Application (2026-2031)
Table 64. Global Octreotide Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Octreotide Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Octreotide Revenue Market Share by Application (2020-2025)
Table 67. Global Octreotide Revenue Market Share by Application (2026-2031)
Table 68. Global Octreotide Price (USD/Gram) by Application (2020-2025)
Table 69. Global Octreotide Price (USD/Gram) by Application (2026-2031)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 73. Novartis Octreotide Product
Table 74. Novartis Recent Developments/Updates
Table 75. Sun Pharmaceutical Company Information
Table 76. Sun Pharmaceutical Description and Business Overview
Table 77. Sun Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 78. Sun Pharmaceutical Octreotide Product
Table 79. Sun Pharmaceutical Recent Developments/Updates
Table 80. Chengdu Tiantaishan pharmaceutical Company Information
Table 81. Chengdu Tiantaishan pharmaceutical Description and Business Overview
Table 82. Chengdu Tiantaishan pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 83. Chengdu Tiantaishan pharmaceutical Octreotide Product
Table 84. Chengdu Tiantaishan pharmaceutical Recent Developments/Updates
Table 85. Sinopharm A-Think Pharmaceuticals Company Information
Table 86. Sinopharm A-Think Pharmaceuticals Description and Business Overview
Table 87. Sinopharm A-Think Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 88. Sinopharm A-Think Pharmaceuticals Octreotide Product
Table 89. Sinopharm A-Think Pharmaceuticals Recent Developments/Updates
Table 90. Sihuan Pharmaceutical Holdings Group Company Information
Table 91. Sihuan Pharmaceutical Holdings Group Description and Business Overview
Table 92. Sihuan Pharmaceutical Holdings Group Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 93. Sihuan Pharmaceutical Holdings Group Octreotide Product
Table 94. Sihuan Pharmaceutical Holdings Group Recent Developments/Updates
Table 95. Shanghai Soho-Yiming Pharmaceuticals Company Information
Table 96. Shanghai Soho-Yiming Pharmaceuticals Description and Business Overview
Table 97. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 98. Shanghai Soho-Yiming Pharmaceuticals Octreotide Product
Table 99. Shanghai Soho-Yiming Pharmaceuticals Recent Developments/Updates
Table 100. Yibin Pharmaceutical Company Information
Table 101. Yibin Pharmaceutical Description and Business Overview
Table 102. Yibin Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 103. Yibin Pharmaceutical Octreotide Product
Table 104. Yibin Pharmaceutical Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Octreotide Distributors List
Table 108. Octreotide Customers List
Table 109. Octreotide Market Trends
Table 110. Octreotide Market Drivers
Table 111. Octreotide Market Challenges
Table 112. Octreotide Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Octreotide
Figure 2. Global Octreotide Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Octreotide Market Share by Type: 2024 & 2031
Figure 4. Octreotide Injection Product Picture
Figure 5. Octreotide Powder Product Picture
Figure 6. Octreotide Microspheres Product Picture
Figure 7. Global Octreotide Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Octreotide Market Share by Application: 2024 & 2031
Figure 9. Treating Severe Diarrhea
Figure 10. Treating Acromegaly
Figure 11. Others
Figure 12. Global Octreotide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Octreotide Market Size (2020-2031) & (US$ Million)
Figure 14. Global Octreotide Sales (2020-2031) & (Gram)
Figure 15. Global Octreotide Average Price (USD/Gram) & (2020-2031)
Figure 16. Octreotide Report Years Considered
Figure 17. Octreotide Sales Share by Manufacturers in 2024
Figure 18. Global Octreotide Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Octreotide Players: Market Share by Revenue in Octreotide in 2024
Figure 20. Octreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Octreotide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Octreotide Sales Market Share by Country (2020-2031)
Figure 23. North America Octreotide Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Octreotide Sales Market Share by Country (2020-2031)
Figure 27. Europe Octreotide Revenue Market Share by Country (2020-2031)
Figure 28. Germany Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Octreotide Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Octreotide Revenue Market Share by Region (2020-2031)
Figure 35. China Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Octreotide Sales Market Share by Country (2020-2031)
Figure 45. Latin America Octreotide Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Octreotide Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Octreotide Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Octreotide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Octreotide by Type (2020-2031)
Figure 55. Global Revenue Market Share of Octreotide by Type (2020-2031)
Figure 56. Global Octreotide Price (USD/Gram) by Type (2020-2031)
Figure 57. Global Sales Market Share of Octreotide by Application (2020-2031)
Figure 58. Global Revenue Market Share of Octreotide by Application (2020-2031)
Figure 59. Global Octreotide Price (USD/Gram) by Application (2020-2031)
Figure 60. Octreotide Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Octreotide market size from 2025 to 2031?
The annual compound growth rate of the global Octreotide market is -2.8% 2025 to 2031.
What was the global market size of Octreotide in 2025?
Which companies rank high in the global Octreotide market?
Which region is expected to have the highest market share?
What was the global market size of Octreotide in 2031?
Related Reports
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 78
USD 4250.00
(Single User License)
Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 2900.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 107
USD 3950.00
(Single User License)
Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 132
USD 4900.00
(Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 137
USD 5900.00
(Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 103
USD 3950.00
(Single User License)
Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-17
Pages: 141
USD 5600.00
(Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-16
Pages: 126
USD 5900.00
(Single User License)
Global Octreotide Market Insights, Forecast to 2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-07
Pages: 96
USD 4900.00
(Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 78
USD 4250.00 (Single User License)Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 2900.00 (Single User License)Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 107
USD 3950.00 (Single User License)Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 132
USD 4900.00 (Single User License)Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 137
USD 5900.00 (Single User License)Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 103
USD 3950.00 (Single User License)Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-17
Pages: 141
USD 5600.00 (Single User License)Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-16
Pages: 126
USD 5900.00 (Single User License)Global Octreotide Market Insights, Forecast to 2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-07
Pages: 96
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now